Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
|
29295717 |
2018 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
|
29335545 |
2018 |
Entrez Id: |
1499 |
Gene Symbol: |
CTNNB1 |
CTNNB1
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
|
28319090 |
2017 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
|
25970160 |
2015 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Integrative molecular profiling of routine clinical prostate cancer specimens.
|
25735316 |
2015 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
|
25908785 |
2015 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
|
25970160 |
2015 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Integrative molecular profiling of routine clinical prostate cancer specimens.
|
25735316 |
2015 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
|
25908785 |
2015 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
|
25062956 |
2014 |
Entrez Id: |
3479 |
Gene Symbol: |
IGF1 |
IGF1
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population.
|
24586243 |
2014 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
|
25062956 |
2014 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
|
23704919 |
2013 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.
|
23248098 |
2013 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
|
23704919 |
2013 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced prostate carcinogenesis in CYP1A-humanized mice.
|
22581815 |
2012 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling.
|
22666205 |
2012 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling.
|
22666205 |
2012 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Therapeutic |
CTD_human |
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
|
22610119 |
2012 |
Entrez Id: |
5728 |
Gene Symbol: |
PTEN |
PTEN
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
|
22610119 |
2012 |
Entrez Id: |
367 |
Gene Symbol: |
AR |
AR
|
Prostatic Neoplasms
|
0.600 |
Biomarker |
CTD_human |
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
|
22610119 |
2012 |